600895 张江高科
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,850,6238.61%4,181,7311,983,3012,025,7381,906,719
减:营业总成本1,891,43021.44%3,419,4231,806,6141,546,1101,584,658
    其中:营业成本1,322,98623.21%2,147,316857,365849,930722,776
               财务费用302,60815.81%541,421521,809456,588420,670
               资产减值损失----17,58224(3,443)(4,747)
公允价值变动收益289,368-3,258.55%(335,478)803,623645,235531,567
投资收益124,858-62.75%672,692211,053205,936119,369
    其中:对联营企业和合营企业的投资收益(233,381)-226.14%323,620(98,602)(515,884)(40,711)
营业利润375,907-20.70%1,075,8321,229,3511,347,5031,000,503
利润总额375,720-20.82%1,267,9861,275,0791,311,856933,263
减:所得税费用133,2075.29%292,016280,695371,210145,618
净利润242,513-30.32%975,970994,383940,646787,645
减:非控股权益(86,902)311.37%(10,152)11,962(7,254)(34,571)
股东净利润329,415-10.76%986,121982,422947,900822,216

市场价值指针
每股收益 (元) *0.210-8.70%0.6200.6300.6100.530
每股派息 (元) *0.064-11.11%0.2000.2000.1900.160
每股净资产 (元) *8.8353.61%8.8148.4628.0347.562
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容